miR‑138‑5p Modulates the Expression of Excision Repair Cross‑complementing Proteins ERCC1 and ERCC4, and Regulates the Sensitivity of Gastric Cancer Cells to Cisplatin

Oncology Reports - Greece
doi 10.3892/or.2018.6907
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

ERCC1 (Excision Repair Complementing Defective Repair in Chinese Hamster)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2015English

AB153. Down-Regulated Expression of Excision of Repair Cross-Complementing Gene 1 Reduces Resistance to Hydroxycamptothecine in Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Excision Repair Cross-Complementing Group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin

Oncotarget
Oncology
2019English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

MIR-138-5P Inhibits the Progression of Prostate Cancer by Targeting FOXC1

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2020English

Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Prognostic Value of Excision Repair Cross-Complementation Group 1 Expression in Gastric Cancer: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

The Tumor Suppressor miR-138-5p Targets PD-L1 in Colorectal Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy